MYRIAD GENETICS, INC.

MYGN ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2025

Total Assets: $706.6M

Liabilities Breakdown FY2025

Total Liabilities: $338.6M